Ligand Pharmaceuticals, Inc.’s recent filing unveils that its Officer Korenberg Matthew E acquired Company’s shares for reported $1.8 million on Aug 09 ’24. In the deal valued at $98.50 per share,18,245 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Korenberg Matthew E sold 18,245 shares, generating $1,797,132 in total proceeds. Upon selling the shares at $98.50, the President & COO now owns 68,368 shares.
Before that, Davis Todd C bought 2,500 shares. Ligand Pharmaceuticals, Inc. shares valued at $243,480 were divested by the Chief Executive Officer at a price of $97.39 per share. As a result of the transaction, Davis Todd C now holds 123,010 shares, worth roughly $12.67 million.
RBC Capital Mkts initiated its Ligand Pharmaceuticals, Inc. [LGND] rating to an Outperform in a research note published on July 30, 2024; the price target was $130. H.C. Wainwright also remained covering LGND and reiterated its “Buy” recommendation on February 04, 2021. Barclays started covering the stock on October 06, 2020. It rated LGND as “an Overweight”.
Price Performance Review of LGND
On Tuesday, Ligand Pharmaceuticals, Inc. [NASDAQ:LGND] saw its stock jump 3.43% to $103.02. Over the last five days, the stock has gained 4.02%. Ligand Pharmaceuticals, Inc. shares have risen nearly 44.25% since the year began. Nevertheless, the stocks have risen 53.26% over the past one year. While a 52-week high of $112.12 was reached on 07/31/24, a 52-week low of $49.24 was recorded on 01/17/24. SMA at 50 days reached $91.76, while 200 days put it at $76.35.
Levels Of Support And Resistance For LGND Stock
The 24-hour chart illustrates a support level at 100.43, which if violated will result in even more drops to 97.85. On the upside, there is a resistance level at 104.32. A further resistance level may holdings at 105.63. The Relative Strength Index (RSI) on the 14-day chart is 57.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.62, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.70%. Stochastics%K at 48.71% indicates the stock is a holding.
How much short interest is there in Ligand Pharmaceuticals, Inc.?
A steep rise in short interest was recorded in Ligand Pharmaceuticals, Inc. stocks on
